IR BioSciences (CE) (IRBS)

IR BioSciences Holdings Inc New (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IRBS

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
24/05/2011	22:28	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
16/05/2011	20:11	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
31/03/2011	17:54	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/03/2011	22:29	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
22/11/2010	21:12	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
12/11/2010	13:27	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
28/10/2010	14:00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
01/10/2010	21:37	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
08/09/2010	12:00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
31/08/2010	19:21	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
25/08/2010	14:00	GlobeNewswire Inc.	University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
23/08/2010	22:15	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
13/08/2010	21:12	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
05/08/2010	13:27	Marketwired	/ CORRECTION - ImmuneRegen BioSciences	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
04/08/2010	12:00	Marketwired	ImmuneRegen BioSciences Completes Successful Reduction of Debt	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
26/07/2010	11:01	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
24/05/2010	20:40	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
17/05/2010	16:51	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
30/04/2010	22:17	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
27/04/2010	13:00	Marketwired	ImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen Me	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
21/04/2010	13:00	Marketwired	ImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead Indica	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
19/04/2010	18:00	Marketwired	ImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
15/04/2010	21:20	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
01/04/2010	21:01	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
04/03/2010	13:00	Marketwired	ImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary Fi	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/02/2010	13:00	Marketwired	Fred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
27/01/2010	13:00	Marketwired	National Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
26/01/2010	19:54	Marketwired	IR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active Compound	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
05/01/2010	13:00	Marketwired	ImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic Influenza	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
24/12/2009	13:00	Marketwired	ImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development Continues	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)